Unspecified kidney failure. Unspecified kidney failure
Conditions
Interventions
Intervention 1: Patients are divided into intervention and control groups. At first, before dialysis, a venous sample is taken from the intervention group (which includes half of the dialysis patients
Sponsors
Yasouj University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Age above 18 years Receive hemodialysis at least twice a week, for 3 months
Exclusion criteria
Exclusion criteria: Positive history of taking anti-inflammatory drugs such as corticosteroids and non-steroidal anti-inflammatory drugs (NSAIDs) in the last month Presence of active, malignant infectious diseases, rheumatic diseases and other obvious inflammatory diseases Patients with a history of kidney transplant and peritoneal dialysis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Protein carbonyl. Timepoint: At the beginning and after 4 weeks. Method of measurement: Oxidized proteins are measured using interactions between carbonylsand 2, 4-dinitrophenylhydrazine to produce a yellow absorption dyeMax at 370 nm. PC level is determined by molar absorption.;LDL. Timepoint: At the beginning and after 4 weeks. Method of measurement: It is measured with an autoanalyzer.;HDL. Timepoint: At the beginning and after 4 weeks. Method of measurement: It is measured with an autoanalyzer.;Bun. Timepoint: At the beginning and after 4 weeks. Method of measurement: It is measured with an autoanalyzer.;Cholesterol. Timepoint: At the beginning and after 4 weeks. Method of measurement: It is measured with an autoanalyzer.;Albomin. Timepoint: At the beginning and after 4 weeks. Method of measurement: It is measured with an autoanalyzer.;Calcium. Timepoint: At the beginning and after 4 weeks. Method of measurement: Measurement with a measuring kit.;Phosphor. Timepoint: At the beginning and after 4 weeks. Method of measurement: Measurement with a measuring kit.;Triglycerides. Timepoint: At the beginning and after 4 weeks. Method of measurement: is measured with an autoanalyzer.;Glutathione peroxidase. Timepoint: At the beginning and after 4 weeks. Method of measurement: It is measured by colorimetric method.;Superoxide dismutase. Timepoint: At the beginning and after 4 weeks. Method of measurement: It is measured using an ELISA kit.;Hs-CRP. Timepoint: At the beginning and after 4 weeks. Method of measurement: Measurement based on latex agglutination.;Potassium. Timepoint: At the beginning and after 4 weeks. Method of measurement: Measure with a measuring kit.;FRAP. Timepoint: At the beginning and after 4 weeks. Method of measurement: The scale of plasma antioxidant capacity in reducing iron ion (Feþ3) is measured based on Benzie and Strain. The blue Fe-TPTZ (Tripyridyl-s-triazine) complex is formed by the reduction of Feþ3 to ferrous ions (Feþ2) at acidic pH. Color | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMoslem Sedaghattalab
Yasouj University of Medical Sciences
Outcome results
None listed